Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...
The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback